Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

307 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The Maillard reaction and food allergies: is there a link?
Toda M, Heilmann M, Ilchmann A, Vieths S. Toda M, et al. Clin Chem Lab Med. 2014 Jan 1;52(1):61-7. doi: 10.1515/cclm-2012-0830. Clin Chem Lab Med. 2014. PMID: 23492561 Review.
Ovalbumin modified with pyrraline, a Maillard reaction product, shows enhanced T-cell immunogenicity.
Heilmann M, Wellner A, Gadermaier G, Ilchmann A, Briza P, Krause M, Nagai R, Burgdorf S, Scheurer S, Vieths S, Henle T, Toda M. Heilmann M, et al. J Biol Chem. 2014 Mar 14;289(11):7919-28. doi: 10.1074/jbc.M113.523621. Epub 2014 Feb 6. J Biol Chem. 2014. PMID: 24505139 Free PMC article.
Here, we aimed to identify specific glycation structure(s) that could influence the T-cell immunogenicity and potential allergenicity of food allergens, using ovalbumin (OVA, an egg white allergen) as a model allergen. ...
Here, we aimed to identify specific glycation structure(s) that could influence the T-cell immunogenicity and potential allergenicity …
Glycation of a food allergen by the Maillard reaction enhances its T-cell immunogenicity: role of macrophage scavenger receptor class A type I and II.
Ilchmann A, Burgdorf S, Scheurer S, Waibler Z, Nagai R, Wellner A, Yamamoto Y, Yamamoto H, Henle T, Kurts C, Kalinke U, Vieths S, Toda M. Ilchmann A, et al. J Allergy Clin Immunol. 2010 Jan;125(1):175-83.e1-11. doi: 10.1016/j.jaci.2009.08.013. Epub 2009 Oct 27. J Allergy Clin Immunol. 2010. PMID: 19864011
Challenges in the implementation of EAACI guidelines on allergen immunotherapy: A global perspective on the regulation of allergen products.
Bonertz A, Roberts GC, Hoefnagel M, Timon M, Slater JE, Rabin RL, Bridgewater J, Pini C, Pfaar O, Akdis C, Goldstein J, Poulsen LK, van Ree R, Rhyner C, Barber D, Palomares O, Sheikh A, Pawankar R, Hamerlijnk D, Klimek L, Agache I, Angier E, Casale T, Fernandez-Rivas M, Halken S, Jutel M, Lau S, Pajno G, Sturm G, Varga EM, Gerth van Wijk R, Bonini S, Muraro A, Vieths S. Bonertz A, et al. Allergy. 2018 Jan;73(1):64-76. doi: 10.1111/all.13266. Epub 2017 Aug 30. Allergy. 2018. PMID: 28771830 Review.
Standardization of allergen products: 2. Detailed characterization of GMP-produced recombinant Phl p 5.0109 as European Pharmacopoeia reference standard.
Himly M, Nandy A, Kahlert H, Thilker M, Steiner M, Briza P, Neubauer A, Klysner S, van Ree R, Buchheit KH, Vieths S, Ferreira F. Himly M, et al. Allergy. 2016 Apr;71(4):495-504. doi: 10.1111/all.12824. Epub 2016 Jan 26. Allergy. 2016. PMID: 26687027
Identification of enolases and aldolases as important fish allergens in cod, salmon and tuna: component resolved diagnosis using parvalbumin and the new allergens.
Kuehn A, Hilger C, Lehners-Weber C, Codreanu-Morel F, Morisset M, Metz-Favre C, Pauli G, de Blay F, Revets D, Muller CP, Vogel L, Vieths S, Hentges F. Kuehn A, et al. Clin Exp Allergy. 2013 Jul;43(7):811-22. doi: 10.1111/cea.12117. Clin Exp Allergy. 2013. PMID: 23786287 Clinical Trial.
10 kDa lipid transfer protein: the main allergenic structure in a German patient with anaphylaxis to blueberry.
Gebhardt C, Vieths S, Gubesch M, Averbeck M, Simon JC, Treudler R. Gebhardt C, et al. Allergy. 2009 Mar;64(3):498-9. doi: 10.1111/j.1398-9995.2008.01923.x. Epub 2009 Feb 12. Allergy. 2009. PMID: 19220224 No abstract available.
Identification of a plane pollen lipid transfer protein (Pla a 3) and its immunological relation to the peach lipid-transfer protein, Pru p 3.
Lauer I, Miguel-Moncin MS, Abel T, Foetisch K, Hartz C, Fortunato D, Cistero-Bahima A, Vieths S, Scheurer S. Lauer I, et al. Clin Exp Allergy. 2007 Feb;37(2):261-9. doi: 10.1111/j.1365-2222.2007.02653.x. Clin Exp Allergy. 2007. PMID: 17250699
The sera of patients sensitized to both LTPs (50%), Pla a 3 and Pru p 3, showed different biological activity in histamine release assay: depending on individual patient's sera tested, Pla a 3 showed a similar, a stronger or a weaker allergenic potency in comparison with P …
The sera of patients sensitized to both LTPs (50%), Pla a 3 and Pru p 3, showed different biological activity in histamine release assay: de …
307 results
Jump to page
Feedback